Incyte (INCY) Misses Q4 EPS by 76c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Incyte (INCY) PT Lowered to $87 at RBC Capital, 'Buyers on Weakness'
February 8, 2022 3:54 PM ESTRBC Capital analyst Brian Abrahams lowered the price target on Incyte (NASDAQ: INCY) to $87.00 (from $90.00) while maintaining an Outperform rating and said they would buy on weakness.
The analyst commented, "4Q featured strong initial launch metrics for Opzelura, solid sales for INCY's core MF... More
Mizuho Securities Reiterates Neutral Rating on Incyte (INCY)
February 8, 2022 7:53 AM ESTMizuho Securities analyst Mara Goldstein reiterated a Neutral rating and $95.00 price target on Incyte (NASDAQ: INCY) following the company's recent earnings report.
For an analyst ratings summary and ratings history on Incyte click here. For more ratings news on Incyte click here.
Shares of Incyte closed at $73.35 yesterday.
... More